Detection of Adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI

This publication has 58 references indexed in Scilit:

• Clinical Pharmacokinetics of Doxorubicin
  Clinical Pharmacokinetics, 1988
• Phase I and II Agents in Cancer Therapy: I. Anthracyclines and Related Compounds
  The Journal of Clinical Pharmacology, 1986
• Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations
  International Journal of Nuclear Medicine and Biology, 1984
• Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity
  American Heart Journal, 1983
• Mechanism of adriamycin cardiotoxicity: Evidence for oxidative stress
  Life Sciences, 1981
• Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
  New England Journal of Medicine, 1979
• Inhibition of the cardiac mitochondrial calcium pump by adriamycin in vitro
  Biochemical Medicine, 1977
• Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
  Science, 1977
• Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells
  Published by Elsevier ,1974
• Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity
  Biochemical and Biophysical Research Communications, 1974